Radiological assessment of the breast following enhancement with Macrolane: Managing the challenges

详细信息    查看全文

• 作者：Gianfranco Scaperrotta^a ; ^{gianfranco.scaperrotta@istitutotumori.mi.it} ; Keshtra Satchithananda^b ; ^{keshthra.satchi@virgin.net} ; Magnus Tengvar^c ; ^{magnus.tengvar@karolinska.se} ; Karin Post^d ; ^{karin.post@t-online.de} ; Adrian K. Lim^e ; Pietro Panizza^f ; ^{ppanizza@sirm.org} ; Ewa Wesolowska^g ; ^ewawu7@wp.pl ; Christopher J. Inglefield^h ; ^{chris@lbps.co.uk}
• 关键词：Hyaluronic acid ; Macrolane ; Breast enhancement ; Breast implants ; Radiological examination
• 刊名：European Journal of Radiology
• 出版年：2017
• 出版时间：January 2017
• 年：2017
• 卷：86
• 期：Complete
• 页码：58-62
• 全文大小：1089 K
• 卷排序：86

文摘

Macrolane VRF®, a biodegradable, stabilized hyaluronic acid gel, was used for breast enhancement 2008–2012. Even after more than 4 years, small amounts of Macrolane can still be visible on magnetic resonance imaging (MRI) or ultrasound in some patients similar to permanent implants, the presence of Macrolane gel may interfere with interpretation of mammography. Knowledge of the product’s appearance on radiological assessment of breasts following Macrolane treatment is therefore required. It is possible to assess the vast majority of patients using a combination of digital mammography and ultrasonography examination.